Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma
HTML
PDF
Details
Locations
Year:
2005
Type:
article
Source:
Blood
DOI:
10.1182/blood-2005-04-1489
Authors:
Thorsten Stühmer,
Manik Chatterjee,
Martin Hildebrandt,
Pia Herrmann,
Hella Gollasch,
Christian Gerecke,
Sebastian Theurich,
Luisa Cigliano,
Rudolf A. Manz,
Peter T. Daniel,
Kurt Bommert,
Lyubomir T. Vassilev,
Ralf C. Bargou
show all 13
Institutions:
F. Hoffmann-La Roche AG,
Max Delbrück Center,
University of Würzburg,
German Rheumatism Research Centre,
Universitätsklinikum Würzburg,
Charité – Universitätsmedizin Berlin
show all 6
Language:
English
Topic:
Cancer-related Molecular Pathways
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Keywords:
multiple myeloma,
p53 pathway,
MDM2 inhibitors,
Nutlin-3,
apoptosis,
bone marrow microenvironment,
stromal cells,
drug resistance,
melphalan,
targeted therapy
show all 10
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
Roche,
Deutsche Forschungsgemeinschaft
Award:
G6993124621
OpenAlex ID:
W2127423053
FWCI:
8.615
Cites:
33
Cited by:
192
Related to:
10